NASDAQ: OVID - Ovid Therapeutics Inc.

Yield per half year: -58.99%
Sector: Healthcare

Current price
1.3 $
Average price
1.98 $ +52.5%

Price based on EPS
2.59 $ +99.43%
Discount price Net Income
1.37 $ +5.57%
10/10

Price based on EPS

Price = Price * (100 - CAGR EPS * Excess Key Rate) / 100
Key Rate = Key rate
Fair price = 2.59 $
Current price = 1.3 $ (difference = +99.43%)


Data

Discounted Cash Flow (Based on EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -14.48 $
Current price = 1.3 $ (difference = -1 213.84%)


Data

Discounted Cash Flow (Based on FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -10.07 $
Current price = 1.3 $ (difference = -874.34%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription